HC Wainwright Reiterates Buy Rating for Cabaletta Bio (NASDAQ:CABA)
HC Wainwright reaffirmed their buy rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a report released on Tuesday morning,Benzinga reports. HC Wainwright currently has a $25.00 price target on the stock. A number of other equities analysts also recently commented on CABA. Wells Fargo & Company downgraded shares of Cabaletta Bio from […]
HC Wainwright reaffirmed their buy rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a report released on Tuesday morning,Benzinga reports. HC Wainwright currently has a $25.00 price target on the stock. A number of other equities analysts also recently commented on CABA. Wells Fargo & Company downgraded shares of Cabaletta Bio from […]
